Longboard Pharmaceuticals, Inc. - Common Stock (LBPH)
59.98
0.00 (0.00%)
Longboard Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies to address the needs of patients with neurological disorders
The company specializes in the research and development of cannabinoid-based medications, leveraging its proprietary technology to create novel treatments aimed at improving the quality of life for individuals suffering from conditions such as epilepsy and other related ailments. Longboard is dedicated to advancing its clinical programs and fostering collaborations within the medical and scientific communities to bring new hope to patients in need.
Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.
H. Lundbeck acquires Longboard Pharmaceuticals for $2.6 billion. The acquisition strengthens Lundbeck's pipeline with bexicaserin, a potential treatment for Dravet syndrome and other neurological conditions.
Shares of Intel Corporation (NASDAQINTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.
Longboard Pharmaceuticals Inc (NASDAQLBPH) shares are trading lower by 11.3% to $22.26 Wednesday afternoon after the company announced that it commenced a $150 million underwritten public offering and expects to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of s
U.S. stocks experienced mixed results in Tuesday’s trading session. The Dow Jones index showed resilience, gaining around 25 points, a modest rise of 0.07% to 37,715.04. In contrast, the tech-heavy NASDAQ faced a downturn, falling 1.63% to 14,765.94. Similarly, the S&P 500 also witnessed a decline, dropping 0.57% to 4,742.83.
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to 14,743.80. The S&P 500 also fell, dropping, 0.66% to 4,738.37.
